Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study. (2022)

First Author: Mahil SK
Attributed to:  Optimising therapeutic strategy in psoriasis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2665-9913(21)00333-7

PubMed Identifier: 34778846

Publication URI: http://europepmc.org/abstract/MED/34778846

Type: Journal Article/Review

Volume: 4

Parent Publication: The Lancet. Rheumatology

Issue: 1

ISSN: 2665-9913